252 results on '"Uchi, Ryutaro"'
Search Results
2. Relationship between immune-related adverse events and the long-term outcomes in recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab
3. Removal of a Metallic Stent after 9 Years of Placement That Caused Tracheal Stenosis: A Rare Case Report
4. Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population
5. Supplementary Figure S4 from The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy
6. Supplementary Table S1 from The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy
7. Supplementary Methods from The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy
8. Data from The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy
9. Supplementary Figure S2 from Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
10. Supplementary Table S1 from Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
11. Supplementary Materials and Methods, Legends for Supplementary Figures from Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
12. Data from Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
13. Study on the treatment outcomes of advanced laryngeal and hypopharyngeal cancer with induction chemotherapy
14. Long term follow up of hearing loss after administration of cisplatin for head and neck cancer
15. Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma
16. Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer
17. 8q24 Polymorphisms and Diabetes Mellitus Regulate Apolipoprotein A-IV in Colorectal Carcinogenesis
18. The miR-506-Induced Epithelial–Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer
19. Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma
20. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer
21. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer
22. Therapeutic effect of Nivolumab for advanced / recurrent temporal bone squamous cell carcinoma
23. Clinical Significance of GAB2, a Scaffolding/Docking Protein Acting Downstream of EGFR in Human Colorectal Cancer
24. Loss of CDCP1 Expression Promotes Invasiveness and Poor Prognosis in Esophageal Squamous Cell Carcinoma
25. Up-regulation of NEK2 by MicroRNA-128 Methylation is Associated with Poor Prognosis in Colorectal Cancer
26. miR-29b is an indicator of prognosis in breast cancer patients
27. Clinical Significance of PICT1 in Patients of Hepatocellular Carcinoma with Wild-Type TP53
28. The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy
29. Establishment and characterization of a primary cell culture derived from external auditory canal squamous cell carcinoma
30. Management of Residual Hearing with Cartilage Conduction Hearing Aid after Lateral Temporal Bone Resection: Our Institutional Experience
31. Clinical Analysis of En Bloc Resection for Advanced Temporal Bone Squamous Cell Carcinoma.
32. Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease
33. Clinical Analysis of En Bloc Resection for Advanced Temporal Bone Squamous Cell Carcinoma
34. Prognostic Significance of Systemic Inflammatory Response in Cases of Temporal Bone Squamous Cell Carcinoma
35. Genomic Sequencing of Cancer-related Genes in Sinonasal Squamous Cell Carcinoma and Coexisting Inverted Papilloma
36. Roles of Therapeutic Selective Neck Dissection in Multidisciplinary Treatment
37. Auricular complications following temporal bone resection for temporal bone malignancies: a clinical consideration
38. Therapeutic effect of Nivolumab for advanced / recurrent temporal bone squamous cell carcinoma
39. Clinical outcome in recurrent and/or metastatic head and neck cancer patients after discontinuation of nivolumab monotherapy due to immune-related adverse events
40. Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
41. Prognostic Impact of Tumor Extension in Patients With Advanced Temporal Bone Squamous Cell Carcinoma
42. Genetic landscape of external auditory canal squamous cell carcinoma
43. A clinical analysis of sinonasal squamous cell carcinoma: a comparison of de novo squamous cell carcinoma and squamous cell carcinoma arising from inverted papilloma
44. Outcome of chemotherapy following nivolumab treatment for recurrent and/or metastatic head and neck squamous cell carcinoma
45. Clinical analysis of tongue squamous cell carcinomas based on the new TNM classification
46. 4 cases that various thrombosis developed in during head and neck cancer treatment
47. Table_1s20190420 – Supplemental material for Small Cell Carcinoma in the Head and Neck
48. Small Cell Carcinoma in the Head and Neck
49. The tolerability of cisplatin with chemoradiotherapy in head and neck carcinoma
50. The role of surgical resection for distant metastasis of head and neck squamous cell carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.